Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

Abstract

Delamanid at all dosages was safe, well tolerated and demonstrated significant exposure-dependent EBA over 14 days, supporting further investigation of its pharmacokinetics and anti-tuberculosis activity.